Search Results

There are 4926 results for: content related to: Alias subtraction more efficient than conventional zero-padding in the Fourier-based calculation of the susceptibility induced perturbation of the magnetic field in MR

  1. You have free access to this content
    Efficacy and safety of certolizumab pegol for Crohn's disease in clinical practice

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 4, August 2015, Pages: 428–440, W. Moon, L. Pestana, B. Becker, E. V. Loftus Jr, K. A. Hanson, D. H. Bruining, W. J. Tremaine and S. V. Kane

    Version of Record online : 17 JUN 2015, DOI: 10.1111/apt.13288

  2. You have full text access to this OnlineOpen article
    Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease

    The Journal of Clinical Pharmacology

    Volume 55, Issue 8, August 2015, Pages: 866–874, Janet R. Wade, Gerry Parker, Gordana Kosutic, Brian G. Feagen, William J. Sandborn, Christian Laveille and Ruth Oliver

    Version of Record online : 13 APR 2015, DOI: 10.1002/jcph.491

  3. Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab′ certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension

    British Journal of Dermatology

    Volume 167, Issue 1, July 2012, Pages: 180–190, K. Reich, J.-P. Ortonne, A.B. Gottlieb, I.J. Terpstra, G. Coteur, C. Tasset and P. Mease

    Version of Record online : 11 JUN 2012, DOI: 10.1111/j.1365-2133.2012.10941.x

  4. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  5. Seizures with Clonazepam: Discontinuation and Suggestions for Safe Discontinuation Rates in Children

    Epilepsia

    Volume 34, Issue 6, November 1993, Pages: 1089–1097, Kenji Sugai

    Version of Record online : 3 AUG 2005, DOI: 10.1111/j.1528-1157.1993.tb02138.x

  6. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  7. Distribution of Plasma Carbamazepine in Epileptic Patients

    Psychiatry and Clinical Neurosciences

    Volume 31, Issue 4, December 1977, Pages: 587–595, Shosuke Watanabe, Chie Kuyama, Shigeo Yokoyama, Shinsuke Kubo and Hiroyuki Iwai

    Version of Record online : 17 MAR 2008, DOI: 10.1111/j.1440-1819.1977.tb00129.x

  8. Clonazepam in a Focal-Motor Monkey Model: Efficacy, Tolerance, Toxicity, Withdrawal, and Management

    Epilepsia

    Volume 20, Issue 6, December 1979, Pages: 683–695, Joan S. Lockard, Rene H. Levy, William C. Congdon, Larry L. DuCharme and Leonard D. Salonen

    Version of Record online : 5 NOV 2007, DOI: 10.1111/j.1528-1157.1979.tb04852.x

  9. Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey

    Inflammatory Bowel Diseases

    Volume 16, Issue 6, June 2010, Pages: 933–938, Alain M. Schoepfer, Stephan R. Vavricka, Janek Binek, Christian Felley, Martin Geyer, Michael Manz, Gerhard Rogler, Philippe de Saussure, Bernhard Sauter, Frank Seibold, Alex Straumann and Pierre Michetti

    Version of Record online : 10 DEC 2009, DOI: 10.1002/ibd.21127

  10. You have free access to this content
    Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 study

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 3, August 2015, Pages: 330–342, W. J. Sandborn, G. Y. Melmed, D. P. B. McGovern, E. V. Loftus Jr, J. M. Choi, J. H. Cho, B. Abraham, A. Gutierrez, G. Lichtenstein, S. D. Lee, C. W. Randall, D. A. Schwartz, M. Regueiro, C. A. Siegel, M. Spearman, G. Kosutic, B. Pierre-Louis, J. Coarse and S. Schreiber

    Version of Record online : 1 JUN 2015, DOI: 10.1111/apt.13251

  11. Improving the temporal resolution of functional MR imaging using keyhole techniques

    Magnetic Resonance in Medicine

    Volume 35, Issue 6, June 1996, Pages: 854–860, Jia-Hong Gao, Jinhu Xiong, Song Lai, E. Mark Haacke, Marty G. Woldorff, Jinqi Li and Peter T. Fox

    Version of Record online : 12 DEC 2005, DOI: 10.1002/mrm.1910350611

  12. Valproate and Clonazepam Comedication in Patients with Intractable Epilepsy

    Epilepsia

    Volume 26, Issue 2, April 1985, Pages: 122–126, Ruy Mirelesh and Ilo E. Leppik

    Version of Record online : 5 NOV 2007, DOI: 10.1111/j.1528-1157.1985.tb05394.x

  13. Influence of Phenytoin and phenobarbital on the disposition of a single oral dose of clonazepam

    Clinical Pharmacology & Therapeutics

    Volume 28, Issue 3, September 1980, Pages: 368–375, Ko-Chin Khoo, Joseph Mendels, Myer Rothbart, William A Garland, Wayne A Colburn, Bo H Min, Rudolph Lucek, John J Carbone, Harold G Boxenbaum and Stanley A Kaplan

    Version of Record online : 19 SEP 1980, DOI: 10.1038/clpt.1980.175

  14. Clozapine use in Parkinson's disease: A retrospective analysis of a large multicentered clinical experience

    Movement Disorders

    Volume 13, Issue 3, May 1998, Pages: 377–382, Richard M. Trosch, Joseph H. Friedman, Meg C. Lannon, Rajesh Pahwa, D. Smith, Lauren C. Seeberger, Christopher F. O'Brien, Peter A. Lewitt and William C. Koller

    Version of Record online : 4 NOV 2004, DOI: 10.1002/mds.870130302

  15. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  16. You have full text access to this OnlineOpen article
    Impact of Certolizumab Pegol on Patient-Reported Outcomes in Patients With Axial Spondyloarthritis

    Arthritis Care & Research

    Volume 67, Issue 10, October 2015, Pages: 1475–1480, J. Sieper, A. Kivitz, A. van Tubergen, A. Deodhar, G. Coteur, F. Woltering and R. Landewé

    Version of Record online : 22 SEP 2015, DOI: 10.1002/acr.22594

  17. Discontinuation of Clonazepam After Long-Term Treatment

    Epilepsia

    Volume 30, Issue 4, August 1989, Pages: 458–463, Ulrich Specht, Hans Erich Boenigk and Peter Wolf

    Version of Record online : 5 NOV 2007, DOI: 10.1111/j.1528-1157.1989.tb05326.x

  18. Fast and accurate method to measure interharmonics in power systems

    European Transactions on Electrical Power

    Volume 6, Issue 3, May/June 1996, Pages: 169–174, X. Dai and R. Gretsch

    Version of Record online : 7 SEP 2007, DOI: 10.1002/etep.4450060305

  19. Clinical effects and plasma concentrations of long-term clonazepam monotherapy in previously untreated epileptics

    Acta Neurologica Scandinavica

    Volume 76, Issue 1, July 1987, Pages: 58–63, H. Naito, M. Wachi and M. Nishida

    Version of Record online : 29 JAN 2009, DOI: 10.1111/j.1600-0404.1987.tb03545.x

  20. Impaired absorption of desmethyldiazepam from clorazepate by magnesium aluminum hydroxide

    Clinical Pharmacology & Therapeutics

    Volume 24, Issue 3, September 1978, Pages: 308–315, Richard I. Shader, Anastasios Georgotas, David J. Greenblatt, Jerold S. Harmatz and Marcia Divoll Allen

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt1978243308